+862985691802
sales@xawanlong.com
Xi'an Wanlong Pharmaceutical Co., Ltd
中文版
切换导航
中文版
HOME
ABOUT US
PRODUCT
API
FDF
CAPABILITIES
R&D
FACILITY
NEWS
CONTACT US
Search
location:
NEWS
Inquiries of Dextran from worldwide clients
We, Xi’an Wanlong Pharmaceutical Co., Ltd, produce 19 APIs at present, which include Dextran series. Recently, we got some inquiries of Dextran from clients.
Release time:2022-12-13
Release time:2022-12-13
Malic Acid Production Using Wild Type Microorganisms
As an intermediate of the TCA cycle, malic acid can be accumulated as a fermentation end-product by various microorganisms including filamentous fungi, yeasts, and bacteria.
Release time:2022-12-09
Release time:2022-12-09
Thrombolysis With Recombinant Tissue Plasminogen Activator and Tirofiban in Stroke
The preliminary results suggest that Recombinant Tissue Plasminogen Activator and Tirofiban(rtPA+T) is a promising option for acute stroke treatment.
Release time:2022-11-30
Release time:2022-11-30
Properties of Dextran
Variations in dextran characteristics (e.g., molecular weight and branching) cause its properties to be different.
Release time:2022-11-23
Release time:2022-11-23
[World Diabetes Day 2022] Epalrestat tablets from Xi 'an Wanlong Pharmaceutical was approved
The approval of Epalrestat tablets from Xi'an Wanlong Pharmaceutical Co., LTD indicates that quality and efficacy of the company's products are consistent with RLD.
Release time:2022-11-15
Release time:2022-11-15
The research of L-malic acid
Malic acid, a four-carbon dicarboxylic acid, is widely used in the food, chemical and medical industries. As an intermediate of the TCA cycle, malic acid is one of the most promising building block ch
Release time:2022-11-10
Release time:2022-11-10
Welcome to visit us at CPHI worldwide 2022 Frankfurt
We, Xi’an Wanlong Pharmaceutical Co., Ltd, have our own stand at CPHI worldwide 2022 Frankfurt. Welcome to visit us from the 1st to the 3rd of November! Stand No.:121D70
Release time:2022-11-01
Release time:2022-11-01
What is tirofiban used for?
Tirofiban is mainly used to treat acute coronary syndrome and prevent thrombosis after coronary arterial intervention.
Release time:2022-10-26
Release time:2022-10-26
CPHI Worldwide 2022
We, Xi’an Wanlong Pharmaceutical Co., Ltd, has our own stand at CPHI worldwide 2022 Frankfurt. Welcome to visit us from the 1st to the 3rd of November!
Release time:2022-10-18
Release time:2022-10-18
Iron Dextran
Iron Dextran is an injectable low-molecular-weight ferric hydroxide complex indicated for patients with iron deficiency anemia where oral iron therapy is ineffective or poorly tolerated.
Release time:2022-10-09
Release time:2022-10-09
Medications for Thrombus
Tirofiban hydrochloride is the first non-polypeptide platelet membrane GP IIb/IIIa receptor antagonist.
Release time:2022-09-21
Release time:2022-09-21
The fermentation principle of L-malic acid
Undoubtedly, increasing the ratio of pyruvate carboxylation can improve the utilization rate of carbon source, that is, can improve the yield of malic acid.
Release time:2022-09-15
Release time:2022-09-15
How long can hydroxyethyl starch go on from the withdrawal from the EU to the revision of the "indication-prohibited" instruction in China?
Compound Dextran 40 injection will become the preferred variety of blood volume expanders and will be brilliant in the field of plasma replacement!
Release time:2022-09-09
Release time:2022-09-09
China's vaccine regulator reaches new WHO rank for safety, quality, efficacy, lays foundation for vaccine exports
The WHO ranked China's vaccine regulatory system at a functional level of maturity according to the WHO's global classification system for national medical product regulatory authorities.
Release time:2022-08-25
Release time:2022-08-25
Announcement of Xi'an Wanlong Pharmaceutical Co., Ltd. Carrying out Cleaner Production Audit
In order to improve the company's environmental benefits, economic benefits and reduce pollutant emissions, in accordance with the notice of the Shaanxi Provincial Department of Ecology and Environmen
Release time:2022-08-18
Release time:2022-08-18
«
1
2
3
4
5
6
7
»